Abstract:Background: Copy number variants platforms, as critical supports for genetic diagnosis, have been well implemented in prenatal diagnosis. However, numerous severe conditions with underlying single-gene defects are not included in current invasive prenatal screening. To bridge this gap, an expanded chromosomal microarray analysis was developed, employing a meticulous designed single nucleotide polymorphism chip. This chip incorporated additional probes to augment its efficacy in screening for spinal muscular atrophy and diagnosing monogenic disorders. Objective(s): This study aimed to evaluate the accuracy, efficacy, and incremental yield of expanded chromosomal microarray, compared with karyotype analysis and low-depth genome sequencing for routine prenatal diagnosis. Study Design: In this prospective study, total of 512 fetuses were included in this study. In this study three distinct diagnostic techniques-karyotype analysis, low-depth genome sequencing, and expanded chromosomal microarray-were processed to evaluate each sample. Aneuploidies and multigene copy number variations were detected and analyzed in a blinded fashion. SMN1 exonic copy number variations were confirmed by multiplex ligation-dependent probe amplification and single nucleotide variations were confirmed by sanger sequencing. Results: Overall, expanded chromosomal microarray identified genetic abnormalities in 91 out of 512 cases (17.6%). The encountered rate was significantly higher than the rates observed with low-depth genome sequencing (66 out of 512 cases, 12.9%) and conventional chromosome karyotyping (42 out of 512 cases, 8.2%). Expanded chromosomal microarray not only detected all these non-mosaic aneuploidies and copy number variations in 62(12.1%) diagnosed cases identified by low-depth genome sequencing (low-depth genome sequencing), but also detected 9 cases with regions of homozygosity, 10(2.0%) cases with exonic deletions (SMN1 and DMD), and 13(2.5%) cases with single nucleotide variations. Conclusions: Compared with low-depth GS, expanded chromosomal microarray increased the additional detection rate by 4.7% (24/512). Compared with traditional chromosomal microarray, expanded chromosomal microarray increased the additional detection rate by 3.9% (20/512) in 512 fetuses. Although the expanded chromosomal microarray (ECMA) has limited accuracy for detecting single nucleotide variations, its screening capacity is significantly enhanced when complemented with Sanger sequencing validation. Using expanded chromosomal microarray, we detected not only copy number variations, but also exonic deletions, regions of homozygosity with high accuracy in an acceptable turnaround time (2-3 weeks). Our results suggest that expanded chromosomal microarray has the potential to be a promising prenatal diagnostic tool with incremental yield of screening exonic copy number variations in SMN1.

Oligonucleotide Microarrays for Clinical Diagnosis of Copy Number Variation

Development Of A Focused Oligonucleotide-Array Comparative Genomic Hybridization Chip For Clinical Diagnosis Of Genomic Imbalance

Standardization and Diversification of Copy Number Microarray Testing for Clinical Diagnostics—Implications of the Cross-Platform/Algorithm Study on Clinical Diagnostic Chromosomal Microarray Analysis

[Application of Single Nucleotide Polymorphism Microarray in Clinical Diagnosis of Intellectual Disability or Retardation].

Genome-wide oligonucleotide array comparative genomic hybridization for etiological diagnosis of mental retardation: a multicenter experience of 1499 clinical cases.

Chromosomal Microarray Analysis in Fetuses with Congenital Anomalies of the Kidney and Urinary Tract: A Prospective Cohort Study and Meta‐analysis

Accuracy Of Cnv Detection From Gwas Data

Density Matters: Comparison of Array Platforms for Detection of Copy-Number Variation and Copy-Neutral Abnormalities.

Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array

Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal cases

Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization

Clinical impact of copy number variation analysis using high-resolution microarray technologies: advantages, limitations and concerns

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

Designing A Simple Multiplex Ligation-Dependent Probe Amplification (mlpa) Assay for Rapid Detection of Copy Number Variants in the Genome

Technology-Driven and Evidence-Based Genomic Analysis for Integrated Pediatric and Prenatal Genetics Evaluation

Methods and strategies for analyzing copy number variation using DNA microarrays

Expanded chromosomal microarray comprising screening for spinal muscular atrophy and monogenic diseases

Identification of Copy Number Variations Associated with Congenital Heart Disease by Chromosomal Microarray Analysis and Next‐generation Sequencing

[The Diagnostic Value of Chromosome Microarray Analysis Technique in the Genetic Causes of Children with Intellectual Disability or Global Developmental Delay].

Analysis of the Factors Affecting the Accuracy of Detection for Single Base Alterations by Oligonucleotide Microarray

Comparative Study of Three PCR-Based Copy Number Variant Approaches , CFMSA , M-PCR , and MLPA , in 22 Q 11 . 2 Deletion Syndrome